Novartis AG (NVS)
154.65
-2.89
(-1.83%)
USD |
NYSE |
Aug 27, 16:00
154.47
-0.18
(-0.12%)
Pre-Market: 09:27
Novartis EPS Diluted (TTM) : 6.629 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.629 |
| March 31, 2026 | 7.017 |
| December 31, 2025 | 7.186 |
| September 30, 2025 | 7.333 |
| June 30, 2025 | 6.886 |
| March 31, 2025 | 6.378 |
| December 31, 2024 | 5.863 |
| September 30, 2024 | 8.574 |
| June 30, 2024 | 7.849 |
| March 31, 2024 | 7.367 |
| December 31, 2023 | 7.144 |
| September 30, 2023 | 3.724 |
| June 30, 2023 | 3.593 |
| March 31, 2023 | 3.255 |
| December 31, 2022 | 3.164 |
| September 30, 2022 | 9.716 |
| June 30, 2022 | 10.22 |
| March 31, 2022 | 10.74 |
| December 31, 2021 | 10.65 |
| September 30, 2021 | 4.333 |
| June 30, 2021 | 3.950 |
| March 31, 2021 | 3.478 |
| December 31, 2020 | 3.518 |
| September 30, 2020 | 3.091 |
| June 30, 2020 | 3.140 |
| Date | Value |
|---|---|
| March 31, 2020 | 5.244 |
| December 31, 2019 | 5.049 |
| September 30, 2019 | 5.069 |
| June 30, 2019 | 4.879 |
| March 31, 2019 | 5.266 |
| December 31, 2018 | 5.377 |
| September 30, 2018 | 5.706 |
| June 30, 2018 | 5.888 |
| March 31, 2018 | 3.417 |
| December 31, 2017 | 3.25 |
| September 30, 2017 | 2.81 |
| June 30, 2017 | 2.74 |
| March 31, 2017 | 2.66 |
| December 31, 2016 | 2.80 |
| September 30, 2016 | 2.84 |
| June 30, 2016 | 2.80 |
| March 31, 2016 | 2.80 |
| December 31, 2015 | 7.28 |
| September 30, 2015 | 7.45 |
| June 30, 2015 | 7.99 |
| March 31, 2015 | 8.290 |
| December 31, 2014 | 4.190 |
| September 30, 2014 | 4.404 |
| June 30, 2014 | 4.004 |
| March 31, 2014 | 3.962 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Roche Holding AG | 2.417 |
| AstraZeneca PLC | 3.330 |
| Johnson & Johnson | 8.628 |
| Eli Lilly & Co. | 29.43 |
| Merck & Co., Inc. | 1.251 |